These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 1326902)

  • 41. Randomized, double-blind, placebo-controlled trial of vigabatrin for the treatment of cocaine dependence in Mexican parolees.
    Brodie JD; Case BG; Figueroa E; Dewey SL; Robinson JA; Wanderling JA; Laska EM
    Am J Psychiatry; 2009 Nov; 166(11):1269-77. PubMed ID: 19651710
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Gamma-hydroxybutyrat (GHB)-dependence and -withdrawal in the case of previous alcohol dependence].
    Richter C; Romanowski A; Kienast T
    Psychiatr Prax; 2009 Oct; 36(7):345-7. PubMed ID: 19173170
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The therapeutic potential of gamma-hydroxybutyric acid for alcohol dependence: balancing the risks and benefits. A focus on clinical data.
    Addolorato G; Leggio L; Ferrulli A; Caputo F; Gasbarrini A
    Expert Opin Investig Drugs; 2009 May; 18(5):675-86. PubMed ID: 19379123
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Gamma-hydroxybutyrate (GHB) for mid/long term treatment of alcohol dependence: a systematic review].
    Brambilla R; Vigna-Taglianti F; Avanzi G; Faggiano F; Leone M
    Riv Psichiatr; 2012; 47(4):269-80. PubMed ID: 23023077
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sodium oxybate in the treatment of alcohol dependence: from the alcohol withdrawal syndrome to the alcohol relapse prevention.
    Skala K; Caputo F; Mirijello A; Vassallo G; Antonelli M; Ferrulli A; Walter H; Lesch O; Addolorato G
    Expert Opin Pharmacother; 2014 Feb; 15(2):245-57. PubMed ID: 24283802
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of fluoxetine on alcohol consumption in male alcoholics.
    Gorelick DA; Paredes A
    Alcohol Clin Exp Res; 1992 Apr; 16(2):261-5. PubMed ID: 1317133
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ability of baclofen in reducing alcohol craving and intake: II--Preliminary clinical evidence.
    Addolorato G; Caputo F; Capristo E; Colombo G; Gessa GL; Gasbarrini G
    Alcohol Clin Exp Res; 2000 Jan; 24(1):67-71. PubMed ID: 10656195
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Acamprosate during and after acute alcohol withdrawal: a double-blind placebo-controlled study in Spain.
    Gual A; Lehert P
    Alcohol Alcohol; 2001; 36(5):413-8. PubMed ID: 11524307
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The safety and efficacy of baclofen to reduce alcohol use in veterans with chronic hepatitis C: a randomized controlled trial.
    Hauser P; Fuller B; Ho SB; Thuras P; Kern S; Dieperink E
    Addiction; 2017 Jul; 112(7):1173-1183. PubMed ID: 28192622
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acamprosate appears to decrease alcohol intake in weaned alcoholics.
    Lhuintre JP; Moore N; Tran G; Steru L; Langrenon S; Daoust M; Parot P; Ladure P; Libert C; Boismare F
    Alcohol Alcohol; 1990; 25(6):613-22. PubMed ID: 2085344
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term effects of and physiological responses to nitrous oxide gas treatment during alcohol withdrawal: a double-blind, placebo-controlled trial.
    Alho H; Methuen T; Paloheimo M; Strid N; Seppä K; Tiainen J; Salaspuro M; Roine R
    Alcohol Clin Exp Res; 2002 Dec; 26(12):1816-22. PubMed ID: 12500105
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gamma-hydroxybutyric acid in the treatment of alcoholism: dosage fractioning utility in non-responder alcoholic patients.
    Addolorato G; Cibin M; Caputo F; Capristo E; Gessa GL; Stefanini GF; Gasbarrini G
    Drug Alcohol Depend; 1998 Dec; 53(1):7-10. PubMed ID: 10933335
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Oxcarbazepine--efficacy and tolerability during treatment of alcohol withdrawal: a double-blind, randomized, placebo-controlled multicenter pilot study.
    Koethe D; Juelicher A; Nolden BM; Braunwarth WD; Klosterkötter J; Niklewski G; Wodarz N; Klatt J; Burtscheidt W; Gaebel W; Markus Leweke F
    Alcohol Clin Exp Res; 2007 Jul; 31(7):1188-94. PubMed ID: 17511748
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treating alcohol dependence with an abuse and misuse deterrent formulation of sodium oxybate: Results of a randomised, double-blind, placebo-controlled study.
    Guiraud J; Addolorato G; Aubin HJ; Batel P; de Bejczy A; Caputo F; Goudriaan AE; Gual A; Lesch O; Maremmani I; Perney P; Poulnais R; Raffaillac Q; Soderpalm B; Spanagel R; Walter H; van den Brink W;
    Eur Neuropsychopharmacol; 2021 Nov; 52():18-30. PubMed ID: 34237655
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Incidence of craving for and abuse of gamma-hydroxybutyric acid (GHB) in different populations of treated alcoholics: an open comparative study.
    Caputo F; Francini S; Stoppo M; Lorenzini F; Vignoli T; Del Re A; Comaschi C; Leggio L; Addolorato G; Zoli G; Bernardi M
    J Psychopharmacol; 2009 Nov; 23(8):883-90. PubMed ID: 18635689
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gamma-hydroxybutyrate reduces both withdrawal syndrome and hypercortisolism in severe abstinent alcoholics: an open study vs. diazepam.
    Nava F; Premi S; Manzato E; Campagnola W; Lucchini A; Gessa GL
    Am J Drug Alcohol Abuse; 2007; 33(3):379-92. PubMed ID: 17613965
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ability of calcium bis acetyl homotaurine, a GABA agonist, to prevent relapse in weaned alcoholics.
    Lhuintre JP; Daoust M; Moore ND; Chretien P; Saligaut C; Tran G; Bosimare F; Hillemand B
    Lancet; 1985 May; 1(8436):1014-6. PubMed ID: 2859465
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparing and combining gamma-hydroxybutyric acid (GHB) and naltrexone in maintaining abstinence from alcohol: an open randomised comparative study.
    Caputo F; Addolorato G; Stoppo M; Francini S; Vignoli T; Lorenzini F; Del Re A; Comaschi C; Andreone P; Trevisani F; Bernardi M;
    Eur Neuropsychopharmacol; 2007 Dec; 17(12):781-9. PubMed ID: 17611081
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A double-blind evaluation of gabapentin on alcohol effects and drinking in a clinical laboratory paradigm.
    Myrick H; Anton R; Voronin K; Wang W; Henderson S
    Alcohol Clin Exp Res; 2007 Feb; 31(2):221-7. PubMed ID: 17250613
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Safety and tolerability of gamma-hydroxybutyric acid in the treatment of alcohol-dependent patients.
    Beghè F; Carpanini MT
    Alcohol; 2000 Apr; 20(3):223-5. PubMed ID: 10869863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.